Neoadjuvant PROSTVAC prior to radical prostatectomy enhances T-cell infiltration into the tumor immune microenvironment in men with prostate cancer

Sater, HA; Marte, JL; Donahue, RN; Walter-Rodriguez, B; Heery, CR; Steinberg, SM; Cordes, LM; Chun, G; Karzai, F; Bilusic, M; Harmon, SA; Turkbey, IB; Choyke, PL; Schlom, J; Dahut, WL; Madan, RA; Pinto, PA; Gulley, JL

Gulley, JL (corresponding author), NCI, Genitourinary Malignancies Branch, Ctr Canc Res, NIH, Bethesda, MD 20892 USA.

JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2020; 8 (1):

Abstract

Background Clinical trials have shown the ability of therapeutic vaccines to generate immune responses to tumor-associated antigens (TAAs). What is re......

Full Text Link